Limited Competition: Strategic Timing of Antiretroviral Treatment (START) (UM1)

The summary for the Limited Competition: Strategic Timing of Antiretroviral Treatment (START) (UM1) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition: Strategic Timing of Antiretroviral Treatment (START) (UM1): The purpose of this limited competition Funding Opportunity Announcement (FOA) is to continue support to complete the Strategic Timing of Antiretroviral Treatment (START) trial. START is a randomized clinical trial to determine if immediate initiation of antiretroviral treatment (ART) in HIV-positive patients is superior in delaying the occurrence of AIDS, non-AIDS events and death.
Federal Grant Title: Limited Competition: Strategic Timing of Antiretroviral Treatment (START) (UM1)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-14-329
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.242, 93.855, 93.856
CFDA Descriptions: Mental Health Research Grants; Allergy, Immunology and Transplantation Research; Microbiology and Infectious Diseases Research
Current Application Deadline: Nov 19, 2014
Original Application Deadline: Nov 19, 2014
Posted Date: August 29th, 2014
Creation Date: Aug 29, 2014
Archive Date: Dec 20, 2014
Total Program Funding:
Maximum Federal Grant Award: none
Minimum Federal Grant Award: none
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following:
Only the current START awardee is eligible to apply to this limited competition FOA.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/PAR-14-329.html
Grant Announcement Contact
NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
More Grants from the National Institutes of Health
Microphysiological Systems (MPS) for Modeling Diabetes (UG3/UH3 Clinical Trial Not Allowed...
Academic Research Enhancement Award in Diseases within the Mission of NIDDK (R15 - Clinica...
Studies in Neonatal and Pediatric Resuscitation (R03 - Clinical Trial Optional)
Using Information Technology to Support Systematic Screening and Treatment of Depression i...
Studies in Neonatal and Pediatric Resuscitation (R01 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2017 FederalGrants.com